Found 1977 matching trials
Prognostic Factors for Survival in Patients With Cholangiocarcinoma N/A The objective of this retrospective study is to determine the survival rate...
Show More Learn More & Join Trial
The Benefit of Surgery in Stage IV of Breast Cancer NA Treatment of Metastatic Breast Cancer is not usually considered curative. R...
Show More Location
Tehran University of Medical Sciences
Learn More & Join Trial
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC PHASE2 This is a single-center, single-arm, phase II clinical study to evaluate th...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test N/A This study prospectively included 150 breast cancer patients (30 patients i...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma PHASE2 The purpose of this study is to evaluate the effectiveness and safety of th...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial
Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection PHASE1 This research study is evaluating a new type of esophagus cancer vaccine ca...
Show More Status
Active Not Recruiting
Location
The Second Affiliated Hospital of Zhejiang University
Learn More & Join Trial
A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study) PHASE2 The major purpose of this study is to examine the anti-tumor activity of th...
Show More Learn More & Join Trial
Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer NA The neoadjuvant system therapy (NAST) can significantly increase the pathol...
Show More Status
Active Not Recruiting
Learn More & Join Trial
NUVOLA TRIAL Open-label Multicentre Study PHASE2 Around 15-25% of ovarian cancer (OC) patients carry germ-line mutation in B...
Show More Location
Fondazione Policlinico Gemelli IRCCS
Learn More & Join Trial
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer PHASE3 A randomized multi-arm study evaluating the efficacy and safety of nivoluma...
Show More Location
Local Institution - 0136
Learn More & Join Trial